These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15458475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in primary glomerulopathies.
    Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A.
    Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
    [Abstract] [Full Text] [Related]

  • 5. Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.
    Bergner R, Hoffmann M, Brass H, Uppenkamp M.
    Clin Nephrol; 2004 Mar; 61(3):207-12. PubMed ID: 15077872
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
    Xu G, Tu W, Jiang D, Xu C.
    Am J Nephrol; 2009 Mar; 29(5):362-7. PubMed ID: 18974636
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolate Mofetil: A Possible Alternative Treatment for IgA Nephropathy.
    Baraldi O, Comai G, Cuna V, Cappuccilli M, Serra C, Ronco C, La Manna G.
    Contrib Nephrol; 2017 Mar; 190():108-116. PubMed ID: 28535523
    [Abstract] [Full Text] [Related]

  • 10. Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials.
    Chen P, Lv J.
    Nephrology (Carlton); 2024 Sep; 29 Suppl 2():25-29. PubMed ID: 39022897
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D, Rasche FM, Carius A, Glander P, Budde K, Bauer S, Keller F, von Müller L.
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of mycophenolate mofetil in the treatment for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Peng XJ, Zheng WM, Fu R, Huang YH, Deng MH, Tao SS, Wang TJ, Zhu C.
    Clin Exp Nephrol; 2021 Jul; 25(7):788-801. PubMed ID: 33710500
    [Abstract] [Full Text] [Related]

  • 13. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study.
    Dal Canton A, Amore A, Barbano G, Coppo R, Emma F, Grandaliano G, Klersy C, Perfumo F, Rizzoni G, Schena FP, Sepe V, Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators.
    J Nephrol; 2005 Jul; 18(2):136-40. PubMed ID: 15944996
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
    Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA.
    Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
    [Abstract] [Full Text] [Related]

  • 16. [Early treatment of IgA nephritis is indicated by prognostic factors].
    Barth C.
    Dtsch Med Wochenschr; 2000 Aug 25; 125(34-35):1009. PubMed ID: 11004913
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy in IgA nephropathy--when and how to do it].
    Vas T, Kovács T, Késoi I, Sági B, Degrell P, Wittmann I, Nagy J.
    Orv Hetil; 2011 Dec 18; 152(51):2039-46. PubMed ID: 22130201
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil in nonlupus glomerulonephropathy.
    Karim MY, Abbs IC.
    Lupus; 2005 Dec 18; 14 Suppl 1():s39-41. PubMed ID: 15803930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil monotherapy in patients who have had kidney transplants.
    Land W.
    Transplantation; 2003 Jun 27; 75(12):2159. PubMed ID: 12829933
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.